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To estimate prevalence of lifetime and current eating disorders (ED) in a sample of pregnant women 
in South-East London, and to describe their socio-demographic and clinical characteristics. 
 
Method 
Secondary analysis of data from a cross-sectional survey. Using a stratified sampling design, 545 
pregnant women were recruited. Diagnostic interviews were administered to assess lifetime and 
current ED, depression, anxiety and borderline personality disorder. Data were extracted from 
maternity records to assess identification of ED in antenatal care. Estimates of population prevalence 
of ED were obtained using sampling weights to account for the stratified sampling design.  
 
Results 
Weighted prevalence of lifetime ED was 15.35% (95% CI, 11.80-19.71%) and current ED was 1.47% 
(95% CI, 0.64-3.35%). Depression, anxiety and history of deliberate self-harm or attempted suicide 
were common in pregnant women with ED. Identification of ED in antenatal care was low.  
 
Conclusions  
Findings indicate that by early pregnancy, a significant proportion of pregnant women will have had 
ED, although less typically during pregnancy, and psychiatric comorbidity is common. Yet ED were 
poorly recognised in antenatal care. The findings highlight the importance of increasing awareness 
about maternal ED to improve identification and response to the healthcare needs of pregnant 










Three key highlights 
 Weighted prevalence of lifetime eating disorders was 15.35% (95% CI, 11.80-19.71%) and 
current eating disorders was 1.47% (95% CI, 0.64-3.35%) in a UK inner-city antenatal sample, 
however, eating disorders were poorly recognised in antenatal care. 
 Depression, anxiety and a history of deliberate self-harm or attempted suicide are common 
amongst pregnant women with eating disorders. 
 Findings highlight the clinical importance of increasing awareness about maternal eating 
disorders in maternity professionals to improve identification and response to the healthcare 
needs of pregnant women with ED. 
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Eating disorders (ED) are a heterogeneous group of mental illnesses characterised by severe 
disturbances in eating behaviour and often associated with significant distress, functional impairment 
and adverse health outcomes (Kessler et al., 2013; Preti et al., 2009; Stice, Marti, Rohde, Nathan Marti, 
& Rohde, 2013). Pregnancy can be a highly emotive period for women with a current or prior history 
of ED as they encounter changes to their body and appetite (Fogarty, Elmir, Hay, & Schmied, 2018; 
Koubaa, Hällström, & Hirschberg, 2008). Most women will adjust as pregnancy progresses with the 
motivation to ensure optimum health of the unborn infant, often experiencing temporary relief from 
their ED symptoms during this time (Fogarty et al., 2018; Micali, Treasure, & Simonoff, 2007). 
However, there is evidence of symptoms persisting for some women, new onset of ED and high risk 
of postnatal relapse (Blais et al., 2000; Micali, Treasure, et al., 2007; Watson et al., 2013).  
 
Symptoms of depression and anxiety during pregnancy are common amongst women with current 
and remitted ED (Easter et al., 2015). Pregnant women with ED are also known to have heightened 
risk of adverse pregnancy and birth outcomes, with risks varying between ED categories and persisting 
among those in remission, including impaired fertility, unplanned pregnancy and delivering low birth 
weight babies in women with lifetime anorexia nervosa (Linna et al., 2013, 2014; Micali et al., 2014; 
Solmi, Sallis, Stahl, Treasure, & Micali, 2014), and miscarriage and delivering large for gestational age 
babies in women with lifetime binge eating disorder (Linna et al., 2013, 2014; Watson et al., 2017). 
Although there is limited research assessing the impact of Other Specified Feeding and Eating 
Disorders (OSFED) on pregnancy and birth outcomes, evidence indicates that sub-threshold ED 
similarly reflect heightened risk (Eik‐Nes et al., 2018; Linna et al., 2013; Watson et al., 2017). 
 
Given the risks associated with maternal ED, early identification and response to healthcare needs is 
imperative to promote optimum maternal and infant outcomes. The UK National Institute for Health 
and Care Excellence (NICE) recommends clinicians should routinely enquire about past and current 
mental illness with all women at their first contact with NHS maternity services (NICE, 2014). NICE 
recommends clinicians should offer women with ED enhanced monitoring and support throughout 
pregnancy into the postnatal period (NICE, 2014, 2017). However, clinicians often lack confidence in 
identifying maternal ED due to inadequate training and public stigma (Bye, Shawe, et al., 2018).  
 
Identifying ED during pregnancy is challenging given typical fluctuations in ED symptoms during this 
time (Blais et al., 2000; Easter et al., 2015; Micali, Treasure, et al., 2007; Watson et al., 2013) and the 
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need to distinguish ED symptoms from pregnancy symptoms, including nausea and vomiting. 
Currently, there is insufficient and conflicting research to accurately determine how many women in 
pregnancy have a current or prior history of ED. It is suggested that between 1.9-7.6% of pregnant 
women may be affected by ED during pregnancy (Easter et al., 2013; Howard et al., 2018; Maihara dos 
Santos et al., 2017; Watson et al., 2013) and 4.5-9.2% pre-pregnancy (Easter et al., 2013; Watson et 
al., 2013). To our knowledge, no studies have reported the prevalence of lifetime ED in pregnant 
women using structured clinical interviews. The inconsistencies in reported prevalence between 
studies are largely due to variations in screening tools in the absence of a validated antenatal 
screening tool, and operationalised ED definitions, especially given the recently revised ED criteria in 
the latest edition of the Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM-5; 
American Psychiatric Association [APA], 2013). This has had important implications for prevalence 
studies (Lindvall Dahlgren, Wisting, & Rø, 2017).  
 
Easter et al (2013), using an adapted version of a standardised self-report instrument and 
classifications pre-emptive but not directly in accordance with DSM-5 (APA, 2013), found 7.5% of 
pregnant women met criteria for current ED and 9.2% met criteria in the period before pregnancy. A 
mother and child cohort study, using a non-standardised self-report instrument and broadly defined 
ED categories, reported a lower prevalence of 5.0% during pregnancy and 4.5% before pregnancy 
(Watson et al., 2013). More recently, two studies (Howard et al., 2018; Maihara dos Santos et al., 
2017) were the first to use diagnostic interviews to establish prevalence of current ED during 
pregnancy in accordance with DSM-5 (APA, 2013). Diagnostic interviews are considered to produce 
more reliable diagnoses than self-report instruments as they enable the interviewer to seek 
clarification where there is ambiguity and given the challenge for self-report instruments to assess 
criterion that are frequently denied i.e. intense fear of weight gain or becoming fat in individuals with 
anorexia nervosa (Stice, Telch, & Rizvi, 2000). Maihara dos Santos et al (2017) reported a prevalence 
of 1.9% for active ED amongst pregnant women, though this study did not assess OSFED. Howard et 
al (2018) reported an overall estimated prevalence of 2% for current ED during early pregnancy 
although it did not include estimates of prevalence for the different types of ED.  
 
This paper presents further secondary analysis of data presented by Howard et al (2018) to expand on 
the reported findings with respect to ED. As ED are a highly heterogeneous group of disorders with 
differing risk profiles between categories and enhanced healthcare needs in women with lifetime as 
well as current ED, it is important to estimate the prevalence of the different types of ED, according 





To estimate the prevalence of lifetime and current ED in a sample of pregnant women in South-East 
London, using structured clinical interviews to establish diagnoses consistent with DSM-5 (APA, 2013), 




























Data were obtained from the WEll-being in pregNancy stuDY (WENDY). WENDY is a cross-sectional 
survey using a sampling design stratified according to women being positive or negative on the 
Whooley questions. The Whooley is a two-item questionnaire to identify symptoms of depression: (1) 
“During the past month, have you often been bothered by feeling down, depressed or hopeless?”; (2) 
“During the past month, have you often been bothered by little interest or pleasure in doing things?” 
(Whooley, Avins, Miranda, & Browner, 1997). “Whooley positive” is determined by an answer of “yes” 
to either of the questions and “Whooley negative” is determined if responses to both questions are 
“no”. Current NICE recommendations are that all women attending NHS maternity services in England 
and Wales are screened using these questions at their antenatal booking appointment, which occurs 
around 10 weeks gestation (NICE, 2014). The primary research aim of WENDY was to establish the 
effectiveness of the Whooley questions to identify antenatal depression. For further detail on the 
rationale, sampling, and representativeness in WENDY see Howard et al (2018). 
 
Ethical approval  
Ethical approval for WENDY was granted by the National Research Ethics Service, London Committee 
- Camberwell St Giles (ref no 14/LO/0075). 
 
Study population and recruitment 
Between November 2014 and June 2016, the WENDY study recruited women attending their 
antenatal booking appointment at an inner-city NHS maternity service in South-East London. All 
Whooley positive women and a random sample of Whooley negative women were selected to be 
approached for participation in the study. Women were eligible to participate if they were 16 years 
old or above and had a response to the Whooley questions recorded on their electronic maternity 
record. Women were ineligible to participate if they had already attended an antenatal booking 
appointment at another maternity service in the UK or had a miscarriage or termination of pregnancy 
prior to the study interview. Eligible women who agreed to participate were recruited within a 
maximum of three weeks from their antenatal booking appointment. Women provided written 
informed consent before the start of the research interview, which also asked for permission to extract 
information from their electronic maternity record. See Figure 1 for the flow chart of women through 





Data collected from the research interview and women’s electronic maternity records are outlined 
below. 
 
Structured Clinical Interview for DSM-IV and DSM-IV-TR Axis I and Axis II disorders  
Researchers administered the Structured Clinical Interview for DSM-IV and DSM-IV-TR Axis I (SCID-I-
Research Version; First, Spitzer, Gibbon, & Williams, 2002) and Axis II disorders (SCID-II; First, Gibbon, 
Spitzer, Williams, & Benjamin, 1997). The SCID is a widely used semi-structured modular interview to 
determine diagnoses consistent with DSM-IV and DSM-IV-TR (APA, 1994, 2000) diagnostic criteria. The 
SCID is a reliable and valid measure for determining diagnoses of mental illnesses (Lobbestael, 
Leurgans, & Arntz, 2011; Zanarini et al., 2000). Although the SCID was not designed to assess DSM-5 
(APA, 2013) diagnostic criteria, we used DSM-5 (APA, 2013) diagnostic criteria to determine diagnoses 
of interest as the DSM-5 version of the SCID was not available at the time of the WENDY study. 
 
SCID-I ED module was used to determine lifetime and current diagnoses of anorexia nervosa, bulimia 
nervosa, binge eating disorder and OSFED, including atypical anorexia, purging disorder and a 
combined category of subthreshold bulimia nervosa or binge eating disorder. As in previous ED 
research (Micali et al., 2017; Smink, van Hoeken, Oldehinkel, & Hoek, 2014; Solmi, Hatch, Hotopf, 
Treasure, & Micali, 2015), the SCID-I ED module ‘skip rules’ were not applied and information on type, 
frequency and duration of ED symptoms were collected to enable classification of diagnoses 
consistent with DSM-5 (APA, 2013). This information was obtained in response to the original SCID-I 
ED module questions without the need for alterations. A current ED diagnosis was determined if all 
criteria were met in the past month. A lifetime diagnosis was determined if all criteria were met at 
any time point, including in the past month.  
 
Evidence indicates diagnostic cross-over between ED over the lifetime is common, more often crossing 
from restrictive to binge/binge-purge types (Anderluh, Tchanturia, Rabe-Hesketh, Collier, & Treasure, 
2009; Eddy et al., 2008). In accordance with previous research, a hierarchical approach was used to 
categorise women who met criteria for more than one lifetime ED diagnosis to ensure diagnostic 
groups were mutually exclusive: full diagnoses (anorexia nervosa; bulimia nervosa; binge eating 
disorder) trumped OSFED subtypes; binge eating disorder trumped bulimia nervosa; bulimia nervosa 
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trumped anorexia nervosa (Micali, Holliday, et al., 2007; Micali et al., 2017). Partial remission of an ED 
was determined if all the criteria were previously met but not all were met in the past month. Full 
remission was determined if all the criteria were previously met but none were met in the past month. 
Age at onset of ED was defined as the age at which a woman first met criteria for an ED as determined 
in the diagnostic interview.  
 
SCID-I mood episodes, mood disorders and anxiety disorders module was used to diagnose common 
mental health disorders, specifically current (in the past month) depression and anxiety disorders. 
Diagnoses of current depression included mild, moderate and severe major depressive episodes and 
mixed anxiety and depression. Diagnoses of any current anxiety disorder included generalised anxiety 
disorder, panic disorder, agoraphobia without panic disorder, social phobia and specific phobia, 
consistent with DSM-5 (APA, 2013) i.e. excluding PTSD and OCD. SCID-II personality disorders sub-
section module was used to establish diagnoses of borderline personality disorder. History of 
deliberate self-harm or attempted suicide was determined from responses to the SCID interview 
questions, including “Have you tried to hurt or kill yourself or ever threatened to do so?” with a follow 
up prompt “Have you ever cut, burned, or scratched yourself on purpose?” (personality disorders sub-
section). Any disclosed act of deliberate self-harm (with or without attempted suicide) was classified 
as a history of deliberate self-harm or attempted suicide.  
 
Training and quality control  
Researchers (postgraduate researchers and research midwives) were trained to administer the 
diagnostic interview. All potential ED cases were discussed in regular supervision meetings to achieve 
consensus on ED diagnoses with NM, eating disorder expert on WENDY, and joint senior author. All 
other potential diagnoses were discussed in consensus meetings with LMH. 
 
Sample characteristics  
Self-reported socio-demographic, obstetric and health information were collected at the research 
interview. Outcomes of interest included  age in years, ethnicity, highest education level, employment 
status, gross annual household income, relationship status, late booking, parity, whether the current 
pregnancy had been planned, whether the current pregnancy was conceived using assisted 
reproductive technology (e.g. in vitro fertilisation), height and pre-pregnancy weight (to calculate pre-
pregnancy BMI), current smoking status, and current or chronic medical conditions. Late bookers were 
defined as women who had their antenatal booking appointment at ≥13 weeks of pregnancy. Self-
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reported pre-pregnancy BMI was calculated as weight (kg) divided by height in metres squared (m2) 
and categorised in accordance with the WHO classification system; underweight (BMI <18.5 kg/m2), 
normal weight (BMI 18.5 - 24.9 kg/m2), overweight (BMI 25.0-29.9), and obese (BMI≥30.0 kg/m2) 
(World Health Organization, 2006).  
 
Information extracted from maternity records 
Of the women who consented for information to be extracted from their electronic maternity record 
(N = 515; 95%), information was extracted on identification of ED at the antenatal booking 
appointment in response to routinely asked questions about past and current severe mental illness 
(National Institute for Health and Care Excellence, 2014). Information was extracted from brief free 
text recorded via the electronic maternity records system by the clinician and categorised 
dichotomously by combining identification of past and/or current ED.  
 
Patient and public involvement and engagement  
An advisory group, comprising of women with lived experience of perinatal mental health problems, 
was established for WENDY and the other related studies undertaken as part of the same programme 
of work (https://www.kcl.ac.uk/ioppn/depts/hspr/research/CEPH/wmh/projects/A-Z/esmi). The 
group met regularly throughout the study period to input into various elements of WENDY, including 
the protocol, study measures, recruitment, participant information sheets and consent forms. No 
members of the advisory group participated in the study or assisted in recruitment. 
 
Analysis 
All data were managed and analysed using STATA 15 (StataCorp, 2017). This study employed a similar 
analysis approach to previously published work (Howard et al., 2018; Nath et al., 2018). Cross 
tabulations and chi-square tests (or Fisher’s exact where appropriate) were used to describe 
differences in sample characteristics, comorbid mental disorders and healthcare outcomes between 
cases and non-cases of lifetime and current ED. Since these were exploratory analyses, we did  not 
perform corrections to the p-values to account for multiple testing. Estimates of population 
prevalence of ED were obtained using sampling weights to account for the stratified sampling design 
(Pickles, Dunn, & Vázquez-Barquero, 1995). More specifically, sampling weights were based on the 
number of Whooley positives and Whooley negatives in the WENDY sample, out of the total number 
of Whooley positives and Whooley negatives that attended their first antenatal booking appointment 
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at the study setting during the study period; this consisted of 906/287 for Whooley positives and 
9057/258 for Whooley negatives (Howard et al., 2018). Population prevalence of lifetime and current 
ED were estimated based on responses from diagnostic interviews (weighted) using the survey (svy) 
command in STATA, which permits stratified sampling and provides robust estimation of 95% 
confidence intervals (CIs).  
 
Missing data 
Among the total sample, 24 (4%) women had some SCID data missing, of which two (0.4%) women 
had missing data for the SCID-I ED module. Missing data for the SCID-I ED module were treated as 
missing observations using list-wise deletion performed in STATA. Only women with complete SCID-I 






















Sample characteristics  
Between 10th November 2014 and 30th June 2016, 10,004 women attended their first antenatal 
booking appointment at the study setting, 41 of whom had no data available on their responses to the 
Whooley questions. The base population was therefore comprised of 9,963 women. Of the women 
identified as eligible to participate (N = 1,647), a total of 545 (33%) women were recruited to WENDY 
and the sample was similar to the base population in age, ethnicity and parity (Howard et al., 2018). 
Of the WENDY sample, 543 women provided responses to the SCID-I ED module (see Figure 1). Women 
with available data for the SCID-I ED module were also similar to the WENDY sample and the base 
population on age, ethnicity and parity (see Table 1). Table 2 represents a comparison of sample 
characteristics between cases and non-cases of lifetime and current ED. Significant differences were 
found between women with lifetime ED (N = 108) and women without lifetime ED (N = 435), with 
women with lifetime ED more commonly being white (66% vs. 49%), educated to degree level or above 
(62% vs. 49%), and in a relationship but not cohabiting (21% vs. 14%). Women with current ED (N = 
16) and women without current ED (N = 527) differed significantly on the distribution of pre-pregnancy 
BMI categories (25% vs. 6% underweight; 33% vs. 64% normal weight; 42% vs. 20% overweight; 0% 
vs. 10% obese, respectively). 
 
Comorbid mental disorders 
Table 3 presents a comparison of comorbid mental disorders between cases and non-cases of lifetime 
and current ED. Women with lifetime ED were significantly more likely to have current depression and 
anxiety compared to women without lifetime ED (34% vs. 25% and 29% vs. 19%, respectively). Women 
with current ED were more likely to have current anxiety and borderline personality disorder 
compared to women without current ED (50% vs. 20% and 19% vs. 2%, respectively). Women with 
lifetime ED were more likely to have a history of deliberate self-harm or attempted suicide compared 
to women without lifetime ED (21% vs. 12%), and this trend was reflected in women with current ED 
compared to women without current ED (31% vs. 13%).  
 
Identification of mental disorders in antenatal care 
Table 4 presents data on mental disorders identified in antenatal care for cases and non-cases of 
lifetime and current ED. Women with lifetime and current ED were more often Whooley positive than 
the women in the comparison groups (66% and 81% vs. 49% and 52%, respectively). Identification of 
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ED at the antenatal booking appointment was low compared to the numbers identified using the 
diagnostic interview (2% vs. 20%).    
 
ED prevalence estimates  
Table 5 presents the weighted population prevalence estimates of lifetime and current ED. The 
weighted lifetime prevalence of ED was 15.35% (95% CI, 11.80-19.71%) and the current prevalence 
was 1.47% (95% CI, 0.64-3.35%). Of full threshold ED, the weighted lifetime prevalence was 9.37% 
(95% CI, 6.66-13.03%) and weighted current prevalence 0.61% (95% CI, 0.19-1.96%). Anorexia nervosa 
was the most prevalent lifetime ED (7.13%; 95% CI, 4.75-10.58%), particularly the subtype restrictive 
anorexia nervosa (5.14%; 95% CI, 3.17-8.23%). OSFED were also common with a lifetime prevalence 
of 5.97% (95% CI, 3.83-9.21%), particularly atypical anorexia (2.63%; 95% CI, 1.31-5.21%). Conversely, 
lifetime prevalence was lowest for bulimia nervosa (0.58%; 95% CI, 0.17-1.97%) and there were no 
current cases of bulimia nervosa. OSFED were the most common ED during pregnancy (0.87; 95% CI, 
0.28-2.69%), particularly purging disorder (0.71; 95% CI, 0.18-2.79%).  
 
Amongst the pregnant women in the sample with lifetime ED (N = 108), there was considerable 
diagnostic cross-over during their life course. Of the women with lifetime anorexia nervosa (N = 42; 
39%), three (7%) were current cases, four (10%) met criteria previously but were current OSFED (one 
atypical anorexia; one purging disorder; two subthreshold bulimia nervosa or binge eating disorder) 
and 35 (83%) were past cases who did not meet criteria for any current ED (34 in full remission; 1 in 
partial remission). Of the women with lifetime bulimia nervosa (N = 8; 7%), none met criteria for any 
current ED (six in full remission; two in partial remission). Of the women with lifetime binge eating 
disorder (N = 22; 20%), six (27%) were current cases, one (5%) met criteria previously but was current 
OSFED (subthreshold bulimia nervosa or binge eating disorder), and 15 (68%) were past cases who did 
not meet criteria for any current ED (14 in full remission; 1 in partial remission). Of the women with 
lifetime atypical anorexia (N = 12; 11%), none met criteria currently (11 in full remission; one in partial 
remission). Of the women with lifetime purging disorder (N = 7; 6%), one (14%) met current criteria 
and six (86%) were in remission (five in full remission; one in partial remission). Of the women with 
lifetime sub-threshold bulimia nervosa or binge eating disorder (N = 17; 16%), one (6%) was a current 
case and sixteen (94%) were in remission (14 in full remission; 2 in partial remission). Of note, all 
women in this study who met criteria for lifetime OSFED only met criteria for one OSFED subtype, so 
it was not necessary to expand the hierarchical approach outlined in the methods section. Amongst 
the women with lifetime ED, the median age of onset for the first ED diagnosis was lowest for the sub-
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threshold bulimia nervosa or binge eating disorder category (16.5, range 14-37) and highest for binge 





























In this UK inner-city antenatal sample of women, the estimated population prevalence for lifetime ED 
was 15.35% (95% CI, 11.80-19.71%) and for active ED during pregnancy was 1.47% (95% CI, 0.64-
3.35%). The findings highlight that by early pregnancy, a significant proportion of women will have 
had ED, although less typically active ED during pregnancy. These findings, together with those of 
previous studies (Fogarty et al., 2018; Koubaa et al., 2008; Linna et al., 2013, 2014; Micali et al., 2014; 
Solmi et al., 2014; Watson et al., 2017), suggest a considerable number of pregnant women are 
vulnerable to adverse pregnancy and birth outcomes and likely to have increased healthcare needs 
during pregnancy and postnatally.  
 
To our knowledge, this is the first study to use diagnostic interviews to estimate population prevalence 
of lifetime ED in pregnant women. The estimated lifetime prevalence reported in this study supports 
a prevalence of 15.33% (95% CI, 13.48–17.42%) reported in a recent study of women who participated 
in a longitudinal birth cohort study, the majority of whom reported that onset of ED was prior to 
pregnancy (Micali et al., 2017). There are marginal discrepancies in prevalence estimates for individual 
ED categories between the studies. Estimated prevalence for lifetime anorexia nervosa of 7.13% (95% 
CI, 4.75-10.58%) was higher in the current study than the prevalence of 3.64% (95% CI, 2.81-4.72%) 
reported by Micali et al (2017). Although this may reflect longer follow-up in the previous findings 
(Micali et al., 2017) as the women were assessed later in life with an average age of 47.78 years 
compared to 32.88 years in this study, considering typical onset of AN is during adolescence (Hudson, 
Hiripi, Pope, & Kessler, 2007). Estimated prevalence for lifetime bulimia nervosa of 0.58% (95% CI, 
0.17-1.97%) was somewhat lower than 2.15% (95% CI, 1.70-2.74%) reported by Micali et al (2017). 
The lifetime prevalence estimate for OSFED of 5.97% (95% CI, 3.83-9.21%) was comparable to a 
prevalence of 7.64% (95% CI, 6.32-9.24%) reported by Micali et al (2017). As evidenced in the study 
findings, a large proportion of pregnant women would be classified with sub-threshold ED despite the 
recent changes to DSM to broaden the full threshold ED categories to reduce the predominance of 
individuals presenting clinically who do not meet full threshold diagnostic criteria (Fairburn & Cooper, 
2011).  
 
The findings indicate that ED may not be as common during pregnancy as some previous reports of 5-
7.6% (Easter et al., 2013; Watson et al., 2013), though it does parallel 1.9% reported by Maihara dos 
Santos et al (2017). None of the women in the current study met diagnostic criteria for bulimia nervosa 
during pregnancy compared to 0.1-0.7% reported previously (Easter et al., 2013; Maihara dos Santos 
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et al., 2017; Watson et al., 2013). This finding likely relates to previous research indicating that most 
women stop or decrease disordered eating behaviours during pregnancy, i.e. self-induced vomiting 
(Micali, Treasure, et al., 2007). Only estimated prevalence for anorexia nervosa during pregnancy 
(0.09%, 95% CI 0.03-0.30%) was similar to a prevalence of 0.1% reported in the more recent study 
(Maihara dos Santos et al., 2017). The high rates of remission during pregnancy found in this study 
indicates that the pre-conception period could be an opportune time for clinicians to identify women 
with a history of ED to assess their current healthcare needs and provide information about pregnancy 
planning to promote optimal physical and mental health prior to pregnancy commencement. Though 
given the increased risk of unplanned pregnancies associated with anorexia nervosa (Micali et al., 
2014), this may not always be plausible.  
 
The discrepancies in reported prevalence of current ED compared to previous antenatal prevalence 
studies may reflect the present study using a more stringent and comprehensive assessment of ED 
diagnoses consistent with DSM-5 (APA, 2013) and warrants further research to replicate the findings 
with a larger cohort of pregnant women. This study used the SCID which is considered one of the “gold 
standard” instruments for establishing ED diagnoses (Lobbestael et al., 2011; Zanarini et al., 2000), 
though it is not without its limitations given it was not designed to assess DSM-5 (APA, 2013) 
diagnostic criteria and the lack of validation studies for assessing OSFED or in antenatal samples. The 
findings highlight the importance of consistency in the diagnostic criteria operationalised in studies 
and support the validation of suitable instruments for use with antenatal populations (Bannatyne, 
Hughes, Stapleton, Watt, & MacKenzie-Shalders, 2018). In a recent article by Paslakis and de Zwaan 
(2019), the lack of appropriate algorithms for identifying ED in pregnant women was highlighted.  
 
It is important to acknowledge though the estimated prevalence of ED may underestimate the true 
proportion as some women may have been reluctant to disclose ED symptoms in the research 
interview, particularly those currently experiencing difficulties, due to fear of being stigmatised and 
negative judgements of them as a mother (Bye, Shawe, et al., 2018). Fear of negative consequences 
as a result of a disclosure may have been a particular concern for women in this study given 
recruitment was via antenatal care, women may have incorrectly assumed that a disclosure could 
impact on their care, despite reassurances from the researchers. Additionally, given the sampling 
weights employed in this study were based on a routine depression screen rather than a screening 
tool for ED, although often comorbid (Easter et al., 2015), this may have resulted in the study not 
capturing all pregnant women who might have ED. This presents an important opportunity for future 




Our findings support previous research that pregnant women with current and past ED often 
experience depression and anxiety during pregnancy (Easter et al., 2015). History of deliberate self-
harm or attempted suicide have not been studied previously in pregnancy but both are associated 
with ED in the general population (Keski-Rahkonen & Mustelin, 2016; Udo, Bitley, & Grilo, 2019). These 
findings highlight the importance for clinicians to assess ED symptoms along with other mental 
disorders during the pregnancy period. We found that pregnant women with lifetime ED were more 
commonly white, well-educated, and in a relationship, which are the types of socio-demographics that 
are often associated with a low risk profile so clinicians may not consider these women to have a 
psychiatric history. This highlights the need for professional training opportunities aimed at enhancing 
awareness on maternal ED to dispel any misconceptions about risk profiles. In this study, pregnant 
women with active ED during pregnancy more commonly presented with pre-pregnancy BMI’s outside 
the healthy weight range. Future research should aim to replicate this finding as it could be a useful 
indicator for clinicians when assessing pre-pregnancy BMI to trigger exploration about the potential 
for active ED.  
 
Amongst the women in this study, ED were poorly identified in antenatal care. The disparity in the 
rate of women identified with ED using a diagnostic interview with those identified at the antenatal 
booking appointment indicates that some women may have intentionally not disclosed symptoms in 
the clinic appointment, but also indicates a lack of or in a few cases, inaccurate diagnoses by clinicians 
(Bye, Shawe, et al., 2018). Recent training initiatives have sought to raise awareness about maternal 
ED (Bye, Walker, et al., 2018; Easter, Bye, Sandall, & Mackintosh, 2018), however opportunities remain 
largely limited. There remains a clear need for professional training programmes and maternity and 
psychiatric services to plan and coordinate efforts to address the deficiencies in clinical recognition of 
maternal ED. Pregnant women with a current or prior history of ED need to be identified as eligible 
for enhanced monitoring and support by knowledgeable clinicians to mitigate risks and help prepare 
women for typical changes, such as reviewing the need for additional growth scans and offering 
enhanced emotional support and advice about weight gain and nutrition (National Institute for Health 
and Care Excellence, 2017).  
 
Strengths  
The main strength was the novel use of structured clinical interviews to obtain estimates of population 
prevalence of lifetime and current ED diagnoses consistent with DSM-5 (APA, 2013) amongst women 
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in early pregnancy. The study sample were diverse and representative of the local inner city 
population, aided by the use of language interpreters for non-English speaking women, which 
supports the generalisability of the findings to similar populations. A wealth of data were collected, 
meaning that we could compare rates of women identified using a diagnostic interview with those 
identified at the antenatal booking appointment. Furthermore, there was minimal missing data on 
study outcomes.  
 
Limitations 
There are several limitations that warrant consideration. The SCID was not designed to assess DSM-5 
(APA, 2013) diagnostic criteria and has not been validated to assess OSFED or for use in antenatal 
samples. The diagnostic interview relied upon recall of ED symptoms during the woman’s life course 
which may have been susceptible to recall bias. Amongst the women in the present study, there was 
diagnostic instability in ED over the lifetime as expected, although this was not as common as 
previously reported (Anderluh et al., 2009; Eddy et al., 2008; Micali et al., 2017). This may be due to 
the ED module being one part of a research interview collecting a wealth of other data whereby ED 
was not the predominant focus of the research. The small sample size for current ED diagnoses limited 
the statistical power to explore group differences and limits the conclusions that can be drawn from 
this sample. Furthermore, the study sample was recruited from a single inner-city maternity site, with 
a poor response rate among those identified as eligible to participate.  
 
Conclusion 
This study estimated the prevalence of lifetime and current ED in a sample of pregnant women in 
South-East London, using structured clinical interviews to establish diagnoses consistent with DSM-5 
(APA, 2013). The findings indicate that by early pregnancy, a significant proportion of pregnant women 
will have had ED, although less typically active ED during pregnancy, and psychiatric comorbidity is 
common. ED were poorly identified in antenatal care, which increases the likelihood of inadequate 
healthcare provision and adverse outcomes for pregnant women with ED. Future research should aim 
to replicate these findings with larger cohorts of pregnant women. The findings make an important 
contribution to the previous research, highlighting the clinical importance of increasing awareness 
about ED to improve identification and response to the healthcare needs of pregnant women with 
lifetime and current ED. Planning of professional training programmes and maternity and psychiatric 
services need to ensure clinicians are able to provide the best standard of healthcare for pregnant 
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Table 1 Characteristics of wider base population and study population 





Sample with  
SCID-I ED data 
  N=9963 N=545 N=543 
Age (in years) 






 <20 232 (2%) 8 (1%) 7 (1%) 
 20-29 3048 (30%) 150 (28%) 149 (27%) 
 30-39 6240 (61%) 341 (63%) 341 (63%) 
 40+ 705 (7%) 46 (8%) 46 (9%) 
Ethnicity     
 White 4914 (51%) 284 (52%) 284 (52%) 
 Black 3162 (33%) 177 (32%)  177 (33%) 
 Asian 594 (6%) 25 (5%) 24 (4%) 
 Mixed   308 (3%) 23 (4%) 22 (4%) 
 Other   646 (7%) 36 (7%) 36 (7%) 
Parity     
 0 5077 (50%) 271 (50%)  269 (50%) 
 1 3209 (31%) 175 (32%) 175 (32%) 
 ≥2 1939 (19%) 99 (18%) 99 (18%) 




Table 2 Comparison of sample characteristics between cases and non-cases of lifetime and current 
ED 
















P value Total 





        
 16-19 7 (2%) - 
P = 0.387 


















 40+ 40 (9%) 6 (6%) 46 (9%) - 
46 
(9%) 
Ethnicity         
 White 213 (49%) 71 (66%) 
















 Asian 21 (5%) 3 (3%) 23 (4%) 1 (6%) 
24 
(4%) 
 Mixed 14 (3%) 8 (7%) 21 (4%) 1 (6%) 
22 
(4%) 













105 (24%) 14 (13%) 





































        
 Employed 275 (63%) 79 (73%) 









 Student 12 (3%) 3 (3%) 15 (3%) - 
15 
(3%) 
 Unemployed 59 (14%) 5 (5%) 64 (12%) - 
64 
(12%) 







due to illness 
or other 
reason 
27 (6%) 7 (6%) 33 (6%) 1 (6%) 
34 
(6%) 
Income ‡         
 < £15,000 60 (19%) 17 (19%) 








































        
 Single 63 (15%) 7 (7%) 


























Parity         
 0 207 (48%) 62 (57%) 





















Late booker         
29 
 
 Yes 78 (18%) 17 (16%) 
P = 0.592 
91 (17%) 
4 













        
 Yes 279 (64%) 76 (70%) 

















        
 Yes 415 (95%) 
103 
(95%) 









































 Underweight 23 (7%) 6 (7%) 

























        
 Yes 16 (4%) 6 (6%) 
P = 0.376 


















        

















† Two women had missing data on employment status (2 non-cases of lifetime/current ED). 
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‡ 128 women had missing data on gross annual household income (111 non-cases of lifetime ED, 17 
cases of lifetime ED; 125 non-cases of current ED, 3 cases of current ED). 
§ 123 women had missing data on pre-pregnancy BMI (100 non-cases of lifetime ED, 23 cases of 
lifetime ED; 119 non-cases of current ED; 4 cases of current ED). 






























Table 3 Comparison of comorbid mental disorders between cases and non-cases of lifetime and 
current ED 
















P value Total 
  N = 435 N = 108  N = 527 N = 16  N = 543 
Current 
depression 























        




















         
 Yes 8 (2%) 5 (5%) 
P = 0.149 
10 (2%) 3 (19%) 

















        
 Yes 52 (12%) 23 (21%) 
P = 0.012 
70 (13%) 5 (31%) 











† One woman had missing data for the SCID-II personality disorders sub-section module (one non-case 
of lifetime/current ED). 
‡ One woman had missing data for history of deliberate self-harm or attempted suicide (one non-case 






Table 4 Comparison of identification of mental disorders in antenatal care between cases and non-
cases of lifetime and current ED 
















P value Total 
  N = 435 N = 108  N = 527 N = 16  N = 543 
Whooley 
status 
























of ED † 
        
 
Yes 
3 (1%) 9 (9%) 
P < 
0.001 













† 46 women had missing data on the identification of ED at the antenatal booking appointment or did 
not consent for information to be extracted from their electronic maternity record (39 non-cases of 



































% (95% CI) 




































































































Figure 1 Flow chart of women through the WEll-being in pregNancy stuDY (WENDY) (n=545) and 
women with complete data on the SCID-I eating disorder module (N = 543; 99%). 
 
 
 
 
 
